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 The interactions of c-myc G–quadruplex with three carbazole derivatives were investigated 
by UV-Vis spectrophotometry, fluorescence, CD spectroscopy, and molecular modeling. The results 
showed that a combination of carbazole scaffold functionalized with ethyl, triazole and imidazole 
groups resulted in stabilization of the intramolecular G-quadruplex formed by the DNA sequence 
derived from the NHE III1 region of c-myc oncogene (Pu22). Binding to the G-quadruplex Pu22 
resulted in the significant increase in fluorescence intensity of complexed ligands 1-3. All ligands 
were capable of interacting with G4 DNA with binding stoichiometry indicating that two ligand 
molecules bind to G-quadruplex with comparable affinity, which agrees with binding model of end-




 G-quadruplexes (G4) are DNA structures that have been found in guanine-rich regions of the 
human genome such as human telomeres [1-4], as well as in promoter regions of certain oncogenes, 
including c-myc [5-7], c-kit [8,9], bcl-2 [10,11] or RET [12,13]. It has been reported that G-
quadruplexes found in many human oncogene promoter regions form three-tetrad intramolecular 
parallel-stranded G-quadruplex structures [5,6,13-19]. The four-stranded structures of G-
quadruplexes are formed by multiple vertically stacked guanine quartets (G-tetrads), which are 
stabilized by Hoogsteen hydrogen bonds, monovalent cations such as potassium and sodium, and can 
be further stabilized by specific ligands [20-24]. In the group of proto-oncogenes, the most 
extensively studied and the best-characterized is the c-myc oncogene, involved in cellular 
proliferation and cell growth, which may also affect inhibition of the apoptosis. The overexpression 
of c-myc can be caused by different mechanisms of transcription and is associated with a wide range 
of human cancers, such as lung, breast, colon, cervix, or leukemia [2,25-29]. In the nuclear 
hypersensitivity element III1 (NHE III1), the guanine-rich DNA sequence containing 27 base-pairs 
located 142-115 bp upstream from the P1 promoter of c-myc, controls 80-90% of the c-myc 
transcription level [7,30-32]. A large number of G-quadruplex stabilizing ligands as promising 
precursors for drug development in anticancer therapy have been described. There are many ligands 
capable of inducing and stabilizing G4 formation in telomeric DNA, which have shown to inhibit 
telomerase activity [23,24,33-47].  
Also a large number of small molecules are potent G-quadruplex ligands that exhibit anti-
proliferative activity in cells [39,48]. Several small molecules, for example cyclic naphthalene 
diimide derivative [43], cationic porphyrins [2,49-52] and pentaheteroaryls [53], quinacridines [52], 














[57], carbazoles [58,59], quindoline derivatives [6,60], platinum [61-64] and cobalt [65] complexes, 
bisquinoline-pyrrole oligoamide [66], indolylmethyleneindanones [67], amido phthalocyanines [68], 
bisbenzimidazole carboxamide derivatives of pyridine, 1,8-naphthyridine, and 1,10-phenanthroline 
[69], or perylene and coronene derivatives [70], have been identified to bind and stabilize G-
quadruplex structures in the c-myc promoter region. Carbazole derivatives are very interesting 
compounds because of their biological and photophysical properties. They are able to target DNA 
structures, some of which have potential for development into anticancer drugs [71,72].  Imidazole 
and triazole groups, as well as carbazole-based compounds, play an important role in medicinal 
chemistry, because many of them exhibit various biological properties - antibacterial, antifungal, 
antiinflammatory, antiparasitic, anticancer, antiviral [73-75]. 
 In this study we present the stability and interaction of three carbazole ligands with G-
quadruplex formed by a sequence corresponding to Pu22 region of c-myc NHE III1. Pu22 is the 
modified mycPu22, the wild-type 22-mer G-rich sequence of the c-myc NHE III1 that forms a 
parallel intramolecular G-quadruplex in the physiological K+ solution. This structure was resolved by 
NMR method after modification of mycPu22 at the 14 and 23 positions (G-to-T substitutions) [6].  
 




 Carbazole derivative 1 was synthesized following the published procedure with some 
modifications [76,77]. Carbazole derivatives 2 and 3 were synthesized by the method reported in our 
previous paper [78]. The purity of ligands was examined by the HPLC technique. These studies were 
performed on a Waters HPLC system 1525 equipped with a Photodiode Array detector 2998 and a 
fluorescence detector 2475, a Breeze interface. A Symmetry®C18 column (dp = 3.5 μm, 75x4.6 mm 





 The quadruplex-forming 22-mer deoxyribonucleotide with c-myc sequence of 5'-
TGAGGGTGGGTAGGGTGGGTAA-3' (Pu22) was purchased from Genomed (Poland) and was 
used without further purification. The strand concentration was determined at 260 nm at 85 °C using 
extinction coefficient of 254600 M-1 cm-1 as calculated from the published values of molar 
absorptivities of nucleotides [79]. Before using, the oligonucleotide solution was heated at 90 °C for 
5 min and subsequently allowed to slow cooling to room temperature, and stored at 4 °C overnight. 
Tris Base (CAS Number 77-86-1) and Tris HCl (CAS Number 1185-53-1) were obtained from 
Aldrich Chemical Co. and used as received. A Milli-Q filtered water (Millipore Co.) was used 
throughout. 
 
2.3. Absorption spectroscopy 
 
 The absorption spectra were recorded on a Cary-100 spectrophotometer (Agilent 
Technologies Australia) in the 300–750 nm range at 25 °C. All of the measurements were carried out 
using a 10 mm quartz cell. UV–Vis absorption titrations were carried out by the stepwise addition of 
1 µl aliquots of 713 µM/strand of G4 DNA Pu22 solution to a cell containing 1000 µl of 6 µM 
ligand. Three minutes was the equilibration time after each DNA addition. All measurements were 
performed in a 10 mM Tris–HCl buffer (pH 7.2) containing 150 mM KCl. 
 















 The fluorescence measurements were carried out using a Jasco FP 8200 spectrofluorimeter. 
The cell compartments were thermostated at 25ºC. All of the measurements were carried out using a 
10 mm quartz cell. The fluorescence spectra were collected from 515 to 750 nm with both excitation 
and emission slits being 5 nm. Fluorescence titrations were carried out by the stepwise addition of 1 
µl aliquots of 367 µM/strand of G4 DNA Pu22 solution to a cell containing 1000 µl of 2 µM ligand. 
Three minutes was the equilibration time after each DNA addition followed by emission spectrum 
recording. Excitation wavelength depended on the absorption spectrum of the ligand. All 
measurements were performed in a 10 mM Tris–HCl buffer (pH 7.2) containing 150 mM KCl. 
The spectra in FID experiment and fluorescence titration experiments with thiazole orange (TO) as a 
fluorescent probe were recorded in the spectral range of 490–750 nm with excitation wavelength at 
480 nm and excitation/emission slits set at 10 nm. In FID experiment the mixture of pre-folded 
oligonucleotide (0.25 μM) and TO (0.5 μM) was allowed to equilibrate for 10 min prior the stepwise 
addition of small portions of ligand 3. In titration experiments the solution of pre-folded 
oligonucleotide (0.25 μM) and carbazole ligand 3 (0.25 μM or 0.5 μM) was allowed to equilibrate 
for 10 min prior the stepwise addition of small portions of TO. The sample solution was incubated 
for 3 min before recording the spectrum to allow equilibration. 
 
2.5. Ligand - Pu22 Binding Study  
 
 Binding data obtained from spectrophotometric and spectrofluorimetric titrations were 
analyzed according to the method of Scatchard and/or using Benesi-Hildebrand transformation [80-
82]. Experiments were carried out in the same manner - after each G4 DNA addition, the titrated 
solution was incubated for 3 minutes followed by the UV-Vis or fluorescence spectrum 
measurement. The titration was continued until only small changes in the absorption or fluorescence 
spectra were observed upon successive addition of Pu22.  
 
The Scatchard model is represented by the equation: 
𝑟
[𝐿]
= 𝐾𝑛 −𝐾𝑟     (1) 
 
where r is the binding ratio (defined as a ratio of bound ligand over the total concentration of DNA 
binding sites), [L] is the concentration of free ligand while K and n correspond to the association 
constant of G4/ligand complex and the number of bound ligand molecules per G-quadruplex, 
respectively. 
 
The method of Benesi-Hildebrand, used to estimate the value of nKb, is represented by the equations 
(2, 3) that describe the n-site ligand binding model: 
  (2) 
  (3), 
where cL is concentration of free ligand, Ao is the absorbance of ligand in the absence of G4 DNA, 
A is the absorbance recorded in the presence of added G4 DNA, Am is absorbance in presence of 
added [G4 DNA]max, Fo is the fluorescence of ligand in the absence of G4 DNA, F is the 
fluorescence recorded in the presence of added G4 DNA, Fm is fluorescence in presence of added 
















2.6. Circular dichroism  
 
 Circular dichroism (CD) spectra were recorded on a Jasco J-810 spectropolarimeter (Jasco, 
Japan), in the spectral range from 210 to 600 nm with 500 nm/min scan speed and bandwidth of 1 
nm. Spectra were recorded in quartz cuvettes of 1 cm path length and averaged from 3 scans. 
Measurements with oligonucleotide were performed at 25 °C in a 10 mM Tris–HCl buffer (pH 7.2) 
containing 100 mM KCl. Concentration of 22-mer oligonucleotide Pu22 was 5 µM / strand. Ligands 
were added to G4 DNA solution at increasing concentration from 0.1 to 5 molar equivalents.  
 In the melting studies, the temperature of the samples were maintained by a Jasco Peltier 
temperature controlled cell holder. The melting profiles of G4: the c-myc G-quadruplex samples 
were prepared by heating the 2 μM oligonucleotide solution in 10 mM Tris HCl buffer, pH 7.2, and 
25 mM or 150 mM KCl at 90 °C for 5 min followed by slow cooling, and storing at 4 °C overnight. 
The melting profiles were recorded in the absence and presence of 3 eq of ligands 1-3 in 10–95°C 
range with 1°C/min scan speed. Also the melting profiles of 2 μM solution c-myc oligonucleotide in 
10 mM Tris HCl buffer (pH 7.2) were recorded in the absence and presence of 3 eq of ligands 1-3 in 
95-10°C range with 1°C/min scan speed. All experiments were carried out using quartz cuvettes with 
a 10 mm optical path. Data were collected at 265 nm. Typically three replicate experiments were 
performed, and average values are reported. 
 
2.7. Molecular modeling studies 
 
 The design protocol we used was based on the combined use of docking and molecular 
dynamics simulations, in which the ligand, the target and the solvent were described by an atomistic 
force field. In particular, we first used the docking calculations in order to establish the favourable 
position of the ligands. We then performed molecular dynamics simulations to check the stability of 
studied complexes. The final quality measure was the average value of the scoring function on a long 
molecular dynamics simulation. The Pu22 sequence from c-myc (PDB ID: 2L7V, 5'-
TGAGGGTGGGTAGGGTGGGTAA-3') promoter region was chosen as a model for G-quadruplex 
for both molecular docking of the ligands and molecular simulations [6]. We used the DNA 
modifications to AMBER force field for system modeling [83-87]. The topologies were generated by 
tleap program in AMBERTOOLS software package [88]. 
 
2.7.1. Ligand docking and modeling 
 
 The quindoline ligands were extracted from the crystal structure (PDB id:2L7V) and 
carbazole ligands 1-3 were re-docked in the same position. The parameters used in obtaining the 
redocked conformation were used to dock other ligands. ICM lig-edit module was used to generate 
ligand 1, 2 and 3. Docking grid was centered on both ends of G-quadruplex structure, taking into 
account all residues around existing ligand (quindoline). For each compound we used The Atomic 
Property Fields superposition template method to obtain the most reliable results [89]. Indoline 
skeleton was used as a template because of its common substructure in both re-docked and carbazole 
ligands. The G-tetrads were restrained in their original conformations throughout the docking 
procedures. The final conformations of the docked complexes were used to carry out molecular 
dynamics simulations. 
 
2.7.2. Molecular dynamics simulations 
 
 The crystal structure of intramolecular parallel-stranded G-quadruplex formed from c-myc 














starting structure for the simulation. 2 K+ ions were added in the central channel between the 
quartets. The structure was explicitly solvated with TIP3PBOX water molecules in a periodic box 
whose boundaries extended at least 10 Å from any solute atom. Additional K+ counter ions were 
added to the system to neutralize the charge on the quadruplex backbone. The counterions were 
automatically placed, using the Coulombic potential, into the most negative locations by the LEAP 
program. Periodic boundary conditions were applied to avoid the edge effect. The particle mesh 
Ewald (PME) method was employed to calculate long-range electrostatic interactions. The AMBER 
ff99sb force field [84] with parmbsc1 [85] and χOL3+OL15 [86,87] modifications were applied for G-
quadruplexes, ions, and water molecules. The ligands were parameterised using the GAFF force field 
[90]. A 10 ns MD equilibration was performed in which system was restrained while solvent and 
ions were allowed to equilibrate. The production run with no restraints on the system was run for 1 
μs (1000ns) simulations using the ACEMD molecular dynamics engine [91]. The trajectories were 
analyzed using the g_rmsd and g_rmsf module available in the GROMACS suite 
(www.gromacs.org) [92], and visualized by means of the VMD program [93] and ICM-Pro Molsoft 
molecular modelling package [94].  
 
2.7.3. Interactions and stability analysis 
 
 To assess the stability of the complexes we calculated RMSD (Root-mean-square-deviation) 
and RMSF (Root-mean-square fluctuations) value through trajectory by using GROMACS package. 
RMSD value is often used to evaluate the stability of complex during simulations. The result allows 
the evaluation of the conformational freedom of loops and G-tetrad and checks the influence of the 
ligands on conformational freedom of the quadruplex structure. AutoDock Vina [95] program were 
used to estimate the binding affinity with using ‘score only’ options. Program allows the calculation 
of the ligand – receptor affinity at predetermined time intervals of the simulation. The scoring 
function that we used was mostly inspired by X-score. As a results we obtained graph of energy 




 Clustering is a useful task to group members of structure, which are similar to each other into 
cluster. To identify the number of structure into clusters it is necessary to use differentiating 
parameters. In our protocol we used RMSD (root mean square deviation) to identify structural 
clusters from a trajectory. RMSD parameter enables to calculate the pairwise distances measured as 
coordinates between structures are defined by a cut-off value reflecting the range of conformations 
and their relative populations. The algorithm generates the most representative centroids structure for 
each cluster and then gives an RMSD for each structure in the trajectory with respect to each 
identified cluster. The MMTSB toolkit code was used with a cut-off of 3.0 Å for all frames from 
trajectory, which were extracted at a time interval of 40 ps for a total of 25 000 frames [85]. 
 




 Our research group identified carbazole derivatives 1-3, as potent G-quadruplex stabilizers 
[78,97,98]. All carbazole cationic ligands were used in our study in the form of iodide salts. As 
shown in Fig. 1, they possess single cationic charge on benzothiazolium moiety, varied length of 
linker R (2 or 4 carbon atoms) attached to the nitrogen atom and to the substituent with different 
electronic nature (an azole rings against aliphatic ethyl chain). Azole moieties such as imidazole 














types of pharmaceuticals that possess a variety of pharmacological activities. Replacement of the 
imidazole substituent with triazole may cause a reduction or an increase in bioactivity [105]. Also a 
combination of two or more types of pharmacophores in one molecule can increase bioactivity 
[74,102]. All the ligand samples were dissolved in DMSO for stock solution 1.5 mM and stored at 4 
°C under light protection before use. These compounds are stable for several months, which was 




Fig. 1. Structures of carbazole ligands 1-3. 
 
To investigate the effect of these carbazole derivatives on parallel intramolecular G-quadruplex 
formed in Pu22 region of c-myc protooncogene (Fig. 2) [6], UV-Vis absorption, fluorescence and 
circular dichroism (CD) techniques, as well as molecular modeling were used. 
 
Fig. 2. Structure of G-quadruplex formed by Pu22 (5'-TGAGGGTGGGTAGGGTGGGTAA-3') 
[PDB ID: 2L7V]. Orange ball = guanine, purple ball = thymine, green ball = adenine.  
 
3.2. UV-Vis absorption spectroscopy  
 
 The ability of ligands to interact with c-myc G-quadruplex DNA was first studied by 
spectrophotometric titration experiments. Carbazole ligands 1-3 form strong complexes with c-myc 
Pu22 sequence as indicated by the visible absorption spectra of carbazole ligands in the absence and 
presence of G-quadruplex (Figs. 3A, S1). The long wavelength maxima of absorption spectra, 
characteristic for carbazole chromophore conjugated with benzothiazolim system via double bond 
C=C, changed dramatically upon addition of G4 DNA, and the bathochromic shifts (λ = 52-57 nm) 
and initial hypochromicity (24-30 %) followed by hyperchromicity (14-32 %) were observed (Table 
1). High values of red shifts and hypochromicity indicate strong stacking interactions between 
carbazole ligands and G-tetrads. The dominant loop or groove binding is less likely, because it would 
not impose such large changes in UV-Vis spectra. This conclusion is confirmed by CD and 
molecular modeling studies (vide infra). 
 
Table 1 




















1 57 30 32 
2 52 24 14 
3 52 28 18 
 
aλ bathochromic shift.  
bHypochromicity and hyperchromicity were measured at λmax. The hypo- and hyperchromicity 
percentages were calculated using following equations: %Hypo = [(Af-Ab,min)/Af]x100 and %Hyper= 
[(Ab,max-Ab,min)/ Ab,max]x100, where Af, Ab,min, Ab,max are the absorbances of free ligand, bound ligand 
with absorbance minimum, and bound ligand with absorbance maximum (excess of G4), 
respectively.  
 
The Pu22/1 complex shows the largest decrease in absorbance (hypochromicity of 30 %), although 
%Hypo values for all ligands are comparable (24-30 %). This indicates that the carbazole ligands/G-
tetrad stacking interactions in these complexes are similar. For the typical intercalation binding 
modes red shifts (at least 15 nm) and large hypochromicities (at least 35%) are generally observed. 
However, these values are determined for long pieces of duplex DNA, where intercalation dominates 
but end-stacking interaction is not important [106]. In addition, no sharp isosbestic points were 
observed. Probably this is the result of multiple conformations for the G-quadruplex and G-
quadruplex-ligand complexes [107]. UV-Vis absorption measurements suggested the two-step 
complex formation between ligands and G-quadruplex. At lower G4/ligand ratios, the positively 
charged ligand may stack onto the phosphate groups of G-quadruplex surface as a result of 
electrostatic attraction. Subsequent redistribution of the ligand molecules at higher G4 concentrations 
is responsible for hyperchromic effect and the interaction of ligand-G4 in another  binding mode, 
namely through the end-stacking interactions. [107-110]. The spectrophotometric titration results 




Fig. 3. Spectrophotometric titration of ligand 1 with Pu22 (A) in Tris-HCl buffer (10 mM, pH 7.2) 
containing 150 mM KCl. Conditions: [L] = 6 µM; titrant: [G4 Pu22] = 713 µM, 10 mM Tris-HCl 
buffer (pH 7.2), 150 mM KCl. Panel B shows normalized absorbance vs. increasing concentration of 
Pu22 G-quadruplex at 506 nm (1), 508 nm (2) and 509 nm (3). 
 















 The binding affinity of carbazole ligands to G-quadruplex c-myc Pu22 was also investigated 
by fluorescence measurements. The fluorescence spectra recorded at λex 506 nm, 508 nm and 509 
nm, respectively for ligands 1, 2, and 3, show that the fluorescence of free ligands in a buffer is quite 
weak. This may be possibly due to the collisional quenching of the excited singlet state by polar 
water molecules [111]. However, the fluorescence increases significantly in the presence of G-
quadruplex c-myc, which may be associated with the hydrophobic environment inside the G-
quadruplex that protects ligand from quenching (ligand fluorescence recovery). The intramolecular 
parallel G-quadruplex in the presence of potassium cations was added to carbazole ligands until very 
small changes in fluorescence spectra were observed. All three complexes showed enhanced 
fluorescence in Tris HCl buffer solutions with a maximum wavelength at about 570 nm. At the same 
time, bathochromic shifts λ = 3 - 5 nm for all ligands were also observed when compared to spectra 
of complexes (Figs. 4A, S2). Among the ligands tested, compound 3 having an imidazole moiety 
attached via N-butyl chain to the carbazole, showed the highest fluorescence enhancement (Fig. 4A).  
 
As shown in Fig. 4A, no plateau was observed for titration plots, instead, a gradual rise in saturation 
plots occurred for all ligands (Fig. S3). Such unusual shape of titration plots may be caused by slow 
complex dissociation or aggregation processes. In these experiments, ligands 2 and 3 with triazole 
and imidazole substituents behaved similarly and their fluorescence enhancement (F/Fo) were 
similar and lower than for ligand 1 with ethyl substituent at the nitrogen atom of carbazole. The 
lower values of F/Fo may be related to the interaction of azole substituents with the loops and to their 
ability to form hydrogen bonds. However, relative enhancement in the fluorescence intensities of all 
ligands is very similar and is correlated with binding constants (Fig. 4C, Table 2). 
 














pH 7.2) containing 150 mM KCl (A); titrant: [G4 Pu22] = 367 µM, 10 mM Tris-HCl buffer (pH 7.2), 
150 mM KCl; Fluorescence enhancement curves (B) and relative enhancement in the fluorescence 
intensities (C) of ligands vs. the increasing concentration of G-quadruplex Pu22; λex: 1 - 506 nm, 2 - 
508 nm, 3 - 509 nm.  
 
3.4. Binding of ligands to G-Quadruplex Pu22 
 
 The UV-VIS and fluorescence titration experiments were used to investigate binding 
behavior of carbazole ligands 1-3 to c-myc G-quadruplex. The titration plots reached saturations 
(Fig. 3 B) therefore they were analyzed according to the simple Scatchard model [74,75]. Because of 
complicated DNA-binding behaviour of ligands 1-3 (blurred isosbestic points, bathochromic shifts, 
initial hypochromicity followed by hyperchromicity), the estimated binding parameters contain 
relatively high uncertainty. On the other hand, fluorescence titration plots (Figs. 4, S2) have not 
reached saturation in the investigated concentration range of G4 DNA, which hampered application 
of Scatchard model. Instead, we used the Benesi–Hildebrand (B-H) method to estimate binding 
affinities of investigated ligands [76]. In this case, Kb values can only be estimated with the 
assumption that stoichiometry of formed ligand/G4 complex is 1:1. Alternatively, result of B-H 
calculation should be regarded as a nKb product (Table 2) (Fig. S3). 
 
The intramolecular G-quadruplex Pu22 possesses two potential ligand binding sites, having similar 
affinities [6]. In the spectrophotometric titration experiments a change in the number of binding sites 
(n) was decreased and amounted to 0.8, 0.9 and 1.1 (unpublished results). In the fluorescence 
titration experiments these values were comparable and amounted to 1, 1.1 and 1.1 for ligands 1,2 
and 3, respectively. It should be emphasized that in all experiments, G-quadruplex was used in much 
excess, which implied that the probability to form G4:ligand complexes of 1:1 stoichiometry is 
higher, than that of 1:2 composition. 
 
Table 2 
Parameters for the interaction of ligands 1, 2 and 3 with Pu22 G-quadruplex determined using 
Benesi-Hildebrand method in fluorescence titration experiments (Kb - binding constant, n - number 
of bound ligand molecules per G-quadruplex; 1 - λe x= 506 nm, 2 - λex=508 nm, 3 - λex=509 nm).  
 
Ligands Benesi-Hildebrand method, nKb 





 The spectral properties of the tested ligands permit their use for direct monitoring of binding 
interactions with oligonucleotides in typical titration experiments with excess of oligonucleotide. 
Such a titration gives binding data concerning the binding site on oligonucleotide but does not 
provide information of limiting stoichiometry of oligonucleoide/dye complex. To find out how many 
carbazole ligands are associated with G4 DNA, we used thiazole orange (TO) as light-up fluorescent 
probe in G-quadruplex Fluorescent Intercalator Displacement assay (G4-FID) [112,113]. It is known 
that thiazole orange binds with high affinity to G-quadruplex DNA structures [114] and the binding 
mode involves the end-stacking interaction of two TO molecules with guanine tetrads [115]. In the 
absence of DNA, the carbazole ligands 1-3 as well as TO show very low fluorescence quantum yield 
values in aqueous solutions. Addition of G-quadruplex DNA causes a remarkable enhancement of 














excitation wavelength of 480 nm characteristic of TO allow to observe binding equilibria of 
competing ligands (λem(TO) = 532 nm and λem(3) = 565 nm). Since stoichiometry of TO/G4 DNA is 
known, the competition titration of the carbazole ligand/G4 DNA complex with TO will provide 
spectral changes, which enable determination of stoichiometry for carbazole ligand/G4 complexes. 
In these experiments, the TO/G4 Pu22 (2:1) complex was titrated with ligand 3 (Fig. 5A) and 
complex of G4 Pu22 with ligand 3 at the molar ratio of 1:1 (Fig. 5B), and 1:2 (Fig. 5C) were titrated 
with TO solution. Addition of equimolar concentration of ligand 3 to TO/G4 complex (Fig. 5A) 
caused disappearence of TO band at 532 nm and evolution of emission at 565 nm in agreement with 
ligand displacement process and further increase in ligand 3 concentration caused enhancement of 
emission of G4/ligand 3 complex. Further evidence of 1:2 stoichiometry of G4/ligand 3 complex was 
provided by FID experiments shown in Figs. 5B and 5C. In the first case (1:1 G4/ligand 3 ratio), TO 
band appeared just after first titrant addition that indicated association of TO molecule to free tetrad 
of G4/ligand 3 complex. As expected, an excess of added TO caused disappearance of ligand 3 
emission band in accordance with displacement of ligand 3. Different spectral patterns were 
observed for titration of G4/ligand 3 solution of 1:2 molar ratio. First two portions of TO did not 
affect seriously the complex emission band at 565 nm suggesting that binding sites on G4 were 
already saturated (compare Fig. 5B and Fig. 5C). Increased concentration of TO resulted in 
broadening of fluorescence band due to the appearance of TO emission at 532 nm. Finally.gradual 
decrease in emission band is observsd that can be explained by the inner-filter effect or formation of 
mixed ligand complexes, in which FRET may operate. 
 
 
Fig. 5. (A) Fluorescence spectra recorded in FID experiment for ligand 3; experimental conditions: 
[G4 Pu22]=0.25 μM, [TO]=0.5 μM, [3] = 0–11.6 μM, 10 mM Tris-HCl buffer (pH 7.2), 150 mM 














experimental conditions: [G4 Pu22]=0.25 μM, [3]= 0.25 μM (B) or 0.5 μM (C), [TO] = 0–3.15 μM, 
10 mM Tris-HCl buffer (pH 7.2), 150 mM KCl; λex = 480 nm. 
 
The binding stoichiometry of ligands 1-3 to G-quadruplex Pu22 was also determined from 
fluorescence titration of G4 DNA with ligand. Changes in fluorescence intensity values of the 
fluorescence bands observed in these experiments are shown in Fig. 6. Upon plotting these values as 
a function of molar equivalents of carbazole ligands added, one obtains the curves nearly saturated 
for complexes with all ligands. However, for all three tested complexes the ligand:G4 Pu22 strand 
ratio is much higher than 1:1, and it is close to binding stoichiometry of 2:1. All our results indicate 
that the interactions between ligands and G-quadruplex Pu22 are not trivial and may involve 




Fig. 6. The increase of normalized fluorescence intensity with added ligands 1-3. 
 
3.5. CD spectroscopy 
 
 Circular dichroism spectroscopy (CD) is a very powerful method for the determination of 
binding modes of ligands to nucleic acid structures. Circular dichroism was used to investigate the 
conformational properties of G-quadruplex c-myc Pu22 treated with the carbazole derivatives. 
Circular dichroism spectra of G4 c-myc Pu22 in Tris HCl buffer were recorded upon addition of 
carbazole ligands 1-3 (Fig. 7A-C). G4 c-myc Pu22 in 100 mM KCl showed a positive signal at about 
265 nm and a negative signal at 241 nm, which suggested a typical parallel G-quadruplex structure 
[116-118]. The decrease of the both signals in the region of the DNA was observed after addtion of 
ligands at higher concentration. Because the position of signals have not changed, this may indicate 
that we don't observe major structural changes of G-quadruplex, but rather the changes in the extent 
of stacking interaction [119,120]. We do not observe positive induced signals (ICD) in the 
longwavelength absorption region of carbazole ligands, which rather exclude the groove binding to 
G-quadruplex structures [121-124]. In all cases, weak negative ICD bands were observed in this 
region. The CD spectroscopic analysis (Fig. 7A-C) showed that these induced signals were red-
shifted above 500 nm. Similar effects were also observed in the UV/Vis titration experiments (Figs. 
2A, S1). It should be noted, that the studied ligands have no optical activity, so they do not exhibit 
CD activity in solution. Thus, the observed CD changes (ICD bands) indicate that the G-quadruplex 
c-myc Pu22 binds the tested compounds in the same way independently of their substituents and the 

















Fig. 7. CD spectra of G-quadruplex Pu22 (5 µM) with increasing concentration of ligands 1 (A), 2 
(B) and 3 (C) in Tris-HCl buffer (10 mM, pH 7.2) containing 150mM KCl. 
 
3.6. DNA melting studies. 
 
 To determine thermal stabilization of G4 c-myc DNA formed in the presence of each ligand, 
compared to that of G4 DNA alone, a CD melting study was performed. Initially, G-quadruplex 
melting experiments were conducted in the presence of 25 mM KCl and 150 mM KCl. Both at high 
(150 mM) and lower (25 mM) salt concentrations, the quadruplex alone and its complexes were very 
stable, therefore the precise melting temperatures could not be determined and it was impossible to 
assess the effect of the ligand binding on stability of the G-quadruplex structure (Table 3). So we 
have studied the G-quadruplex-complex forming ability through measurements of the thermal 
melting profiles of the c-myc Pu22 oligonucleotide incubated with carbazole ligands in the absence 
of K+. At the wavelength 265 nm, at which there is the characteristic positive CD signal assigned to 
the oligonucleotide Pu22 and a typical parallel G-quadruplex c-myc structure, significant thermal 
stabilization was observed after addition of ligands 1-3. (Fig. 8, Table 3) [60]. Additionally, the 
melting curves of the oligonucleotide Pu22 showed a hysteresis in the reverse scan, while hysteresis 




















a  Tm [°C]
b  Tm [°C]
c  Tm [°C]
d  
No drug 23.4  ---  76.8  78.4  
1 47.6  24.2  > 80  > 80  
2 47.2  23.8  > 80  > 80  
3 55.2  31.8  > 80  > 80  
 
a Tm of oligonucleotide Pu22 in the absence of salt. 
b Tm were obtained from the differences in the melting temperatures of the 3 eq ligand bound and 
oligonucleotide Pu22 in 10 mM Tris-HCl buffer (pH 7.2). Data were collected at 265 nm. Typically 
three replicate experiments were performed, and average values are reported within  1 °C of each 
other. 
c Tm values of G4 Pu22 incubated in the presence of 25 mM KCl (lit. 75.5 °C in 20 mM K
+) [5]. 




Fig. 8. Normalized CD melting profiles of Pu22 oligonucleotide at 265 nm without and with 3 eq of 
ligands 1-3 in 10 mM Tris-HCl buffer (pH 7.2). 
 
3.7. Molecular modeling studies. 
 
 All ligands (1-3) were docked based on template position of indoline structure. Indoline was 
chosen because it is a common structure, both in quindoline and carbazole. Docking procedures 
using The Atomic Property Fields (APF) methods in ICM Molsoft program [94] dock ligands based 
on maximum overlap with the template position. We observe small differences between position of 
our ligands and template due to difference in the structure and substituents and adaptation to the 
conformation of the flanking loop residues. We observed that significant binding forces between 
tetrads and ligands were end-stacking interactions. Triazole and imidazole moieties from ligand 2 
and 3 interact at 3' end with T11-A12 loop and at the 5' end with external T1-G2-A3 loop. Both 
represent almost similar positions after docking procedure. As a result, we obtained ∆G values for 


















Fig. 9. Docked ligands 1, 2 and 3 on external G-tetrads of intramolecular parallel-stranded type of G-
quadruplex. Cartoons (a) and (b) represents the side view of the complex. In (a), the 5’ end is 
illustrated as sticks and the 3’ end in a surface representation. In (b) the 3’ end is illustrated as sticks 
and the 5’ end in a surface representation. The next two illustrations highlight the top view of the (c) 
5’ and (d) 3’ ends. 
 
 Evaluation of the stability of Pu22/1,2,3 complexes was assessed based on the interactions 
and ligand dynamics (Fig. S4). In case of ligand 1 we observe small movement of ligand at the 5' end 
where carbazole interacted by end-stacking with guanines G6 and G10. We did not observe any 
interactions with the external T19-A20-A21 and T1-G2-A3 loops. Ligand 2 exhibits good stability at 
the 5' end. The ligand interacts by end-stacking mode with the tetrad (G4-G7-G13-G17) while 
triazole moiety is located in the groove making hydrogen bonds (Fig. S5). We did not observe the 
same behaviour for ligand 2 at the 3’end of G-quadruplex. Ligand 3 translates a lot during 
simulations due to large freedom of the imidazole moiety with butyl chain linker, which causes 
destabilization of the two flanking, T19-A20-A21 and T1-G2-A3 loops. Due to this behaviour there 
were a lot attractive and repulsive interactions between them, which makes both ligand and end loop 
mobile.  
 Analysis of the RMSD value (Fig. S6-S7) indicates that our system is indeed well 
equilibrated but not converged at the current timescale. The results highlight that ligand 2 possesses 
the best stabilization properties of the three ligands. The structure of G-quaduplex was stable over 
the course of the simulations. RMSF values (Fig. S8-S9) indicate that two loops T19-A20-A21 and 
T1-G2-A3 at the ends of the structure are flexible. The triazole moiety interacts with T11-A12 bases 
and stabilizes that loop, as compared to G4 when no ligand is present. Two significant transition 














of the external residues T1-G2-A3. The position of the T1 and interaction between them and external 
G-tetrad (G4-G8-G13-G17) determined observed transition states (Fig. S10). We also observed 
biggest fluctuations for loop T11-A12 in complex Pu22/1. Ligand 1 interacted with tetrads by end-
stacking interactions without any movements in the directions of the groove. Also ligand 3 did not 
create any stable interactions (besides end-stacking), which would enhance the stability of the 
complex. RMSF value for G-quadruplex DNA without ligands indicate that two loops T19-A20-A21 
and T1-G2-A3 were most stable when compared to other complexes. It is connected with the fact 




Fig. 10. Binding energy [kcal/mol] computed from the simulations (at 5 frame interval). Blue line 
represents Pu22/1 complex, pink line represent Pu22/2 complex and yellow line represent Pu22/3 
complex.  
 
We computed the value of the binding energy for every 5th frame in the trajectories (Fig. 10) [95]. 
We observed the lowest value for complexes Pu22/2 (average value -20.35 [kcal/mol]), for Pu22/3 
(average value -19.77 [kcal/mol]) and Pu22/1 (average value -16.61 [kcal/mol]). These results are in 
agreement with the conclusions from clustering analysis, RMSF and RMSD analysis and confirm 
that ligand 2 better stabilizes the studied G-quadruplex structure. We also observed that after about 
200 ns system is equilibrated and the values of binding energy did not change significantly. The 
obtained results for the complex Pu22/1 indicate that ligand 1 does not interact with the same affinity 
with the G-quadruplex. This might be due to interactions just with the tetrad and not with any groove 















Fig. 11. Conformational clusters obtained by clustering analysis for G-quadruplex-ligand 2 complex. 
RMSD-based clustering, with a cut-off of 3.75 Å, identified three clusters. Cartoon representations 
of top (at the 3' end) and side view of cluster centers are illustrated (top 3' end). The violet is a 
transitional state observed within the black and yellow cluster. 
 
Clustering analysis was conducted for G-quadruplex complex with ligands 1, 2, 3 and without any 
ligand. The aim of clustering analysis is to identify the main substates sampled during the course of 
the simulation. A 3.75 Å RMSD cut-off identified 5 clusters for DNA conformations simulated 
without ligand (Fig. S11), 3 clusters for DNA conformations simulated with ligand 1 (Fig. S12 and 
Fig. S13) and 2 clusters for DNA conformations simulated with ligand 3 (Fig. S14, Fig. S15). In this 
section we discuss results of G-quadruplex simulated with ligand 2, while details for ligand 1 and 3 
can be found in the supplementary section. A 3.75 Å RMSD cut-off identified three clusters for DNA 
conformations in complex with 2 (Fig. 11). The top cluster accounted for ~69% of the sampled 
conformational space. The difference between the obtained clusters and transitional cluster (violet) is 
connected with conformation of the T1-G2-A3, T19-A20-A21 and T11-A12 loops (Fig. S16). 
Position of adenine A21 is different in each cluster. Loop T1-G2-A3 is more stable than loop T20-
A21-A22 where we observed many changes in the position of all three nucleotides. While we 
observed alignment of the A3 and G2 nucleotides from the same loop in three centroids on the 5’end 
loop, we couldn’t indicate any such alignment of nucleotides in the 3’end loop. We observe that 
residues A12 and T11 change conformation when the triazole interacts with the groove. The centroid 
which represent black cluster corresponds to the G-quadruplex structures conformations that are 





 The main aim of this work was to investigate the interaction of three carbazole ligands, 
differing in substituent at nitrogen atom of carbazole, with G-quadruplex formed by the DNA 
sequence derived from the NHE III1 region of c-myc oncogene (Pu22). The binding of compounds 1-
3 was investigated by UV-Vis spectrophotometry, fluorescence, CD spectroscopy, and molecular 
modeling. The results have shown that all ligands have ability to stabilize the intramolecular G-
quadruplex Pu22 and interact by the same binding mode. The spectrophotometric titration results 
have shown a trend towards large hypochromicity at lower G4/ligand ratios followed by 
hyperchromic effect at higher G4 concentrations, which indicates the presence of more than one 
binding mode.Being weakly fluorescent in aqueous solution, these vinylic derivatives of carbazole 
display strong fluorescence enhancement when bound to c-myc G-quadruplex. CD melting studies 
indicate that the ligands have the ability to form and stabilize the c-myc G-quadruplex structure. The 
experimental results indicate that the ligand 1 shows the strongest interactions with the tested c-myc 
G-quadruplex, however, the strength of interaction with ligand 2 is almost at the same level. This is 
consistent with the results of molecular modeling, where ligand 2 possessed the best stabilization 
properties of G-quadruplex. However, the simple correlation between energy values and complex 
stability was not observed, which indicates that strong interactions between ligand and G-quadruplex 
do not necessarily result in better stability of the system. Altogether, the data indicate that carbazole 
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